Health information — Educational information, not medical advice. Talk with your healthcare provider about your care and treatment decisions.
Modern HIV treatment is one of medicine's greatest achievements. Whether you were just diagnosed or have been living with HIV for years — this hub covers everything from ART basics and U=U to long-acting injectables, adherence, and how to access care — with expanded resources for Floridians navigating a changing landscape.
1 pill
a day is an option for many people starting HIV treatment[2]
Zero
risk of sexual transmission when undetectable (U=U)[1]
Long life
is possible with early diagnosis and staying on treatment[15]
Since 1987
of progress — from AZT, the first HIV drug, to modern combination treatment[10]
Updated September 2026. Refreshed with NIH/HHS adult and adolescent antiretroviral guidelines, the Cabenuva and Sunlenca approvals, hepatitis C coinfection guidance, Florida ADAP bridge funding, and the Liverpool drug-interaction checker.
Your first steps, what to expect, how to find care in Florida, Ryan White explained, and answers to the questions you're afraid to ask. Built specifically for this moment.
When you're ready to go deeper on treatment, this seven-step reading path walks you through everything — from understanding your labs to paying for medications — at your own pace. One thing worth knowing before you start: federal guidelines recommend antiretroviral therapy for everyone living with HIV, regardless of CD4 count, and recommend starting as soon as possible after diagnosis — sometimes the same day.[4]
HIV treatment is antiretroviral therapy (ART). Everyone living with HIV should be on it, treatment should start as soon as possible after diagnosis, and pills are the recommended starting point for people just beginning.[2] Before you start, your provider sends a blood sample for genotypic resistance testing — but that test should not delay getting you on medication.[4] Expect a viral load check within four to eight weeks after starting or changing an HIV regimen [30], and know that most people get HIV under control within six months.[2] Long-acting options have also arrived: Cabenuva was approved in January 2021 as the first complete extended-release injectable regimen,[7] lenacapavir (Sunlenca) was approved in December 2022 for heavily treatment-experienced adults with multidrug-resistant HIV,[8] and lenacapavir was approved as twice-yearly PrEP under the name Yeztugo in June 2025.[9]
Answer three questions for suggested reading and questions to bring to your care team. This tool cannot determine medication eligibility, interpret labs, or choose a regimen.
Treatment Path Finder
Find your starting point
3 questions. 30 seconds. No personal information collected.
Step 1 of 3
Where are you in your HIV treatment journey?
Step 2 of 3
How do you feel about taking a daily pill?
Step 3 of 3
How important is cost and insurance coverage to your decision?
Getting to undetectable is a health goal, not a measure of your worth. Fear, stigma, grief, fatigue, housing instability, or a difficult experience with care can make treatment feel heavier. Tell your team what is getting in the way. You deserve respectful care and practical support at every viral load.
Modern HIV medicine works because it is taken. The HHS clinical guidelines panel treats adherence as a continuum — something clinicians and patients build together across every visit, not a one-time hurdle at diagnosis.[21] Missed doses can let the virus rebound and, over time, allow resistance mutations to develop that can narrow future options.[5] Most people find a routine that works — a paired-with-coffee habit, a phone alarm, a weekly pill organizer, or discussing whether long-acting treatment is clinically appropriate and whether timely injection visits are practical.
Build the Routine
What Actually Helps People Stay On Treatment
Link doses to a daily routine and follow the medicine’s storage and food instructions. Ask whether longer refills are available. Before travel, ask your pharmacist for a time-zone and missed-dose plan specific to your regimen; carry enough medicine for delays.
Nausea, headaches, sleep changes, and vivid dreams are common in the first few weeks and usually settle. Rash with fever, yellowing eyes or skin, or new depression need prompt medical advice. A severe rash, blistering, facial swelling, or trouble breathing needs urgent care; call 911 for breathing difficulty. Suspected serious drug reactions need immediate assessment before another dose, because stopping the suspected medicine may be necessary.[6]
No one should go without HIV treatment because of cost. These resources cover the major pathways to affordable care — from federal programs to manufacturer assistance. The Ryan White HIV/AIDS Program pays for medical care, medications, and support services for low-income people with HIV, reaches more than half of everyone diagnosed with HIV in the country each year, and is designed to work as a payer of last resort alongside whatever other coverage you have.[17] If you are uninsured, underinsured, or your coverage just changed, a Ryan White case manager is a useful place to start.
Florida ADAP: where things stand
Florida's AIDS Drug Assistance Program lowered income eligibility from 400% to 130% of the federal poverty level effective March 1, 2026, eliminated insurance premium assistance except for people who are self-insured, and restricted access to certain medications.[18] State lawmakers then appropriated $30.9 million in bridge funding that restored program eligibility at 400% of the federal poverty level through June 30, 2026.[18] The Florida Department of Health's current ADAP criteria list income eligibility at 0–400% of the federal poverty level, and the department states that it is not providing premium assistance at this time.[19] Rules here have changed more than once in a single year — confirm your own eligibility with your Ryan White case manager or ADAP before making any coverage decision. Read the full ADAP breakdown →
Being on treatment for a long time does not mean being on the same pills for a long time. The HHS guidelines explicitly cover optimizing therapy in people who are already virally suppressed — simplifying a regimen, moving off older medications with more side effects, cutting pill burden, or switching to a long-acting injectable are all recognized reasons to change.[22] Any switch is planned around your resistance history and current viral load, so bring both to the visit.[5]
Reasons to Bring Up a Switch
These Are Clinical Conversations, Not Complaints
Side effects that are wearing you down. Pill fatigue. A regimen you have to hide from a partner or family. New meds (statins, GLP-1s, hormones, acid reducers) that may interact. Wanting to try an injectable. Planning a pregnancy. A change in kidney or liver labs.
Current viral load (usually undetectable to switch smoothly), your genotype/resistance history, hepatitis B status, kidney function, and any other prescriptions you're taking. Some switches are same-day; others need a bridge plan.
Cabenuva (monthly or every two months)[7] and lenacapavir-based regimens for treatment-experienced adults[8] are injectable options with different eligibility rules. Cabenuva is a complete regimen; Sunlenca must be combined with other active HIV medicines.[27]
If you have hepatitis B, stopping medicines that also treat HBV can cause a serious flare. Your clinician must preserve effective HBV treatment when changing ART. Before a switch or injection, confirm the next dose, pharmacy or clinic access, and what to do if a visit is delayed. [22]
Some combinations of ART, other medicines, and supplements need dose timing, closer monitoring, or a different prescription. These interactions can lower ART levels, raise the other medication's levels, or cause new side effects. The September 24, 2026 NIH/HHS update retired its current interaction tables and now directs clinicians to the Liverpool checker for detailed interaction guidance,[23] and the University of Liverpool's HIV Drug Interactions checker is the widely used bedside reference for looking up individual combinations.[24] Before any new prescription, over-the-counter medication, or supplement, tell the prescriber you are on ART — and if you can, check with your HIV provider or pharmacist too.
Common Interactions to Flag
Bring These Up First
Acid reducers (PPIs like omeprazole, H2 blockers), statins for cholesterol, hormonal contraception, gender-affirming hormones, anti-seizure medications, some antibiotics and antifungals, methadone or buprenorphine, and rifampin for tuberculosis. Also: St. John's wort, high-dose calcium/magnesium/iron supplements taken near dosing.
Free, clinician-grade, updated regularly. Search two or more medications and see the interaction level and clinical guidance. Not a substitute for your provider — but useful to bring to the visit. hiv-druginteractions.org →
A person living with HIV who is on treatment and maintains an undetectable viral load has zero risk of sexually transmitting HIV to their partners.[1] That is the whole of U=U. The updated U=U guide brings together ten years of the movement, the evidence, and people’s experiences of relief and renewed intimacy. Viral suppression is defined as having fewer than 200 copies of HIV per milliliter of blood, and HIV medicine can push the amount of virus so low that a test cannot detect it at all.[3] This is not a reduced risk or a hopeful estimate — and it is one of the strongest reasons to start treatment and stay on it.
Hepatitis A, B, and C are different viruses. A and B have vaccines; hepatitis C has no vaccine, but modern treatment can usually cure it. Review tests, protection, treatment, and medication interactions together. [25][26]
If you are living with HIV and have not been tested for hepatitis C — or if you were tested years ago and are at ongoing risk — ask your provider about HCV screening at your next visit. Treatment is 8–12 weeks of oral medication and cures more than 95% of cases.[14] Your HIV status does not prevent you from being cured. Read the full guide →
The HIV population in the United States has been aging for years. Of the more than 1.1 million people living with diagnosed HIV in 2023, roughly 54% were aged 50 and older — a share that keeps growing as effective treatment extends life expectancy.[15] Aging with HIV brings its own care questions: cardiovascular risk, bone density, kidney function, cognition, cancer screening, and how the growing list of non-HIV prescriptions fits alongside ART.
Polypharmacy — commonly defined as taking five or more prescriptions at the same time — is common among older adults living with HIV. Every added medication is another chance for an interaction with ART.[23] Bring your full list — including supplements and anything a specialist prescribed — to every HIV visit and ask if anything can be simplified or deprescribed.[22]
Ask your care team about blood pressure, cholesterol, kidney health, bone health, and cancer screening. Tests and vaccines should fit your age, treatment history, and risk factors. Bring up memory, mobility, mood, or connection concerns—and the activities you want to keep enjoying.
Treatment doesn't happen in a vacuum — it happens inside a life that includes aging, other prescriptions, insurance, and everything else. These longer guides go deeper on the parts that shape treatment over time. For age-related care, see the Aging section.[15]
U=U means zero risk of sexual transmission when you are undetectable[1] — but disclosure is a legal question as well as a personal one. Florida's communicable disease statutes make it a criminal offense for a person who knows they have HIV to have sexual intercourse with another person without first informing them and obtaining their consent, and the statute is not written around viral suppression.[20] Many advocates recommend talking with your provider, and where possible a legal advocate familiar with Florida's HIV criminalization laws, before making decisions about disclosure. Read about Florida HIV criminalization laws →
Viral suppression is defined as having fewer than 200 copies of HIV per milliliter of blood.[3] Most people get HIV under control within six months, and some suppress much faster.[2] Your provider will usually check a viral load within four to eight weeks after you start or change a medication, then at intervals set by your care team.[30][2] Taking your medication consistently is what gets you there and what keeps you there.
A single missed dose is rarely a crisis, but the response depends on your specific medication. Follow your medicine’s missed-dose instructions or ask a pharmacist; the allowed timing differs between products. Do not take an extra dose unless the instructions specifically call for it. Repeatedly missed doses are more concerning, because HIV that keeps replicating can develop resistance to the medications you're taking — which is exactly what drug-resistance testing is designed to detect and steer around.[5] Talk to your provider if you're struggling. There are real solutions, including different regimens and injectable ART.
HIV (Human Immunodeficiency Virus) is the virus itself. AIDS (Acquired Immunodeficiency Syndrome) is the most advanced stage of HIV disease — reached when someone's CD4 count falls below 200 cells/mm³ or they develop an AIDS-defining opportunistic illness.[11] HIV medicines can slow or prevent HIV from advancing from one stage to the next, which is why so few people on consistent treatment reach this stage today. And even if someone’s HIV has already progressed to AIDS, HIV medicines can still bring the virus down to undetectable levels and allow more CD4 cells to regenerate.[11]
With current technology, yes — ART controls the virus but doesn't eliminate it. The obstacle is that latent virus remains in cells known collectively as the HIV reservoir, and if someone with ART-suppressed HIV stops taking their medication, virus from that reservoir rebounds. Federally funded cure research is working on both clearing the reservoir and keeping it suppressed without daily medication.[12] That research is active and ongoing, but it is not yet something you can ask for at a clinic visit.
Long-acting injectable treatment exists and is given once a month or once every other month depending on the plan; Cabenuva is approved for eligible adults and adolescents aged 12 or older weighing at least 35 kg with viral suppression, no history of treatment failure, and no known or suspected resistance to cabotegravir or rilpivirine. The clinician also checks interactions and hepatitis B treatment needs.[29][2] Lenacapavir (Sunlenca) was approved in December 2022 for heavily treatment-experienced adults with multidrug-resistant HIV,[8] and lenacapavir was separately approved as twice-yearly PrEP under the name Yeztugo in June 2025.[9] Availability in any given part of Florida depends on your clinic and your coverage — ask your HIV provider whether you're a candidate. Learn more about Cabenuva or find a provider near you.
Alcohol and other substances can affect your liver, your daily routine, and sometimes your medications themselves. Heavy use also makes consistent adherence harder, which is the part that puts treatment at risk. Tell your HIV provider and your pharmacist everything you take — prescriptions, over-the-counter products, supplements, and anything else — so they can check for interactions and adjust if needed. Accurate information keeps you safer, and there is no judgment in saying it out loud.
A resistance test (genotype) checks whether your strain of HIV carries mutations that make certain medications less effective. Guidelines recommend drug-resistance testing at entry into care to guide the choice of your first regimen, and again in the setting of virologic failure.[5] Resistance can develop when the virus keeps replicating while medication levels are too low — which is why consistent adherence matters so much. Your provider uses the results to pick a regimen your virus is fully susceptible to. Learn more in the medication guide.
Yes — and you should. With effective ART during pregnancy and birth and appropriate infant medication, transmission risk can be reduced below 1%. Breastfeeding is a separate discussion: sustained suppression lowers its risk to below 1%, but not zero; properly prepared formula or pasteurized banked donor milk eliminates transmission through breast milk.[28][16] ART is recommended during pregnancy; the best regimen depends on current perinatal guidance, your treatment history, and your circumstances. If you're already on ART when you become pregnant, do not stop — contact your provider to review your regimen. If you're newly diagnosed during pregnancy, treatment should start immediately. Read more about HIV & women.
Modern ART is far better tolerated than earlier regimens, but antiretrovirals can still have adverse effects — and the specific risks depend on which drugs you take, which is why federal guidelines maintain a drug-by-drug table of common and severe adverse effects.[6] Areas providers commonly monitor include kidney function, bone density, lipids, glucose, and weight. That is why regular lab work is part of ongoing HIV care rather than an optional extra. Most side effects are manageable, and switching regimens is always on the table if something isn't working for you. Understand your lab results.
A note on this content: The information on this hub covers HIV treatment, medications, lab values, legal rights, and access to care. It is provided for educational purposes only and is not medical or legal advice. HIV treatment decisions, medication changes, and disclosure obligations depend on your individual health situation and applicable laws. Always work with a qualified HIV provider for treatment decisions. For questions about your legal rights — including Florida’s HIV criminalization statutes — consult a legal professional familiar with HIV law. Full disclaimer →
Every numbered claim on this page links to the source it came from. We prioritize primary clinical, public-health, and regulatory sources — CDC, the NIH/HHS antiretroviral guidelines panel, NIAID, FDA, HIV.gov, HRSA, and Florida state government for Florida-specific guidance. Guidance and eligibility rules change; when in doubt, check the source and talk with your provider or case manager.
